Contact hours available until 4/30/2022.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Faculty, Planners and Authors Conflict of Interest Disclosure:
The author(s), editor, editorial board, content reviewers, and education director reported no actual or potential conflict of interest in relation to this continuing nursing education article.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
This educational activity is provided by the Society of Urologic Nurses and Associates (SUNA).

The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556.

This article was reviewed and formatted for contact hour credit by Michele Boyd, MSN, RN, NPD-BC, SUNA Education Director.

Learning Outcome:
After completing this education activity, the learner will be able to discuss how prophylactic use of an alpha-2 adrenergic receptor agonist may attenuate CRBD, a postoperative complication characterized by a burning sensation, bladder discomfort, and the urge to urinate.

Tito D. Tubog CRNA, DNAP, APRN, CCRN-CSC, CMC

Appearances